SCHEMBL30128757

SCHEMBL30128757

CC(NO)c1ccc2ccccc2c1

nearest known ligand 0.63

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MMP9 P14780 1/20 0.63
▸ UGT2B7 P16662 1/20 0.62
▸ MEN1 O00255 2/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ CYP2D6 P10635 2/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ HIF1A Q16665 1/20 0.53
▸ ATM Q13315 1/20 0.49
▸ PDE2A O00408 1/20 0.46
▸ SLC6A2 P23975 4/20 0.45
▸ SLC6A4 P31645 4/20 0.45
▸ SLC6A3 Q01959 4/20 0.45
▸ KCNH2 Q12809 3/20 0.45
▸ AOC3 Q16853 1/20 0.45
▸ ALOX5 P09917 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2255110 1.00 MMP9 (0.63) MMP9UGT2B7MEN1KMT2ACYP2D6
SCHEMBL12871846 0.83 UGT2B7 (0.61) MMP9UGT2B7MEN1KMT2ACYP2D6
SCHEMBL1320202 0.82 UGT2B7 (0.59) MMP9UGT2B7MEN1KMT2ACYP2D6
SCHEMBL13804034 0.82 UGT2B7 (0.59) MMP9UGT2B7MEN1KMT2ACYP2D6
SCHEMBL28276305 0.82 UGT2B7 (0.59) MMP9UGT2B7MEN1KMT2ACYP2D6
SCHEMBL19286311 0.82 UGT2B7 (0.59) MMP9UGT2B7MEN1KMT2ACYP2D6
SCHEMBL178531 0.82 UGT2B7 (0.59) MMP9UGT2B7MEN1KMT2ACYP2D6
SCHEMBL23742756 0.80 UGT2B7 (0.57) MMP9UGT2B7MEN1KMT2ACYP2D6
SCHEMBL15979349 0.80 UGT2B7 (0.57) MMP9UGT2B7MEN1KMT2ACYP2D6
SCHEMBL23742881 0.80 UGT2B7 (0.62) MMP9UGT2B7MEN1KMT2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240294470-A1 FRAGRANCE COMPOUNDS GIVAUDAN SA (CH) 2024-09-05 — — US disclosed
EP-4355728-A1 FRAGRANCE COMPOUNDS Givaudan SA (CH) 2024-04-24 — — EP disclosed
CN-117500783-A Perfume compounds 奇华顿股份有限公司 2024-02-02 — — CN disclosed
WO-2022263605-A1 FRAGRANCE COMPOUNDS GIVAUDAN SA (CH) 2022-12-22 — — WO disclosed
WO-2022261956-A1 FRAGRANCE COMPOUNDS GIVAUDAN SA (CH) 2022-12-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240294470-A1 FRAGRANCE COMPOUNDS FASN, FAAH2, FADS2 MMP9 2320/4885UGT2B7 435/4885MEN1 4388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback